Page last updated: 2024-08-20

perylene and Non-alcoholic Fatty Liver Disease

perylene has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bai, M; Bao, Y; Huang, Y; Li, Y; Liang, C; Liu, L; Song, Z; Sun, L; Wang, S; Yang, H; Yi, J; Yu, C	1

Other Studies

1 other study(ies) available for perylene and Non-alcoholic Fatty Liver Disease

Article	Year
Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo. Pharmacological research, 2020, Volume: 153 Topics: AMP-Activated Protein Kinases; Animals; Anthracenes; Apoptosis; Cell Differentiation; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Male; Mesenchymal Stem Cells; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Perylene; Reactive Oxygen Species	2020

Article

Year

Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo.

Pharmacological research, 2020, Volume: 153

Topics: AMP-Activated Protein Kinases; Animals; Anthracenes; Apoptosis; Cell Differentiation; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Male; Mesenchymal Stem Cells; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Perylene; Reactive Oxygen Species

2020